AbbVie posts trial win for multiple myeloma drug (ABBV)
AbbVie posts trial win for multiple myeloma drug (ABBV) Seeking Alpha
Covered in this story
Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.